Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.15M Sell
21,959
-2,158
-9% -$567K 0.53% 60
2026
Q1
$6.43M Buy
24,117
+511
+2% +$138K 0.64% 58
2025
Q4
$5.92M Sell
23,606
-593
-2% -$157K 0.56% 62
2025
Q3
$6.95M Sell
24,199
-353
-1% -$94.6K 0.66% 59
2025
Q2
$6.45M Sell
24,552
-416
-2% -$101K 0.64% 60
2025
Q1
$5.81M Sell
24,968
-345
-1% -$83.7K 0.62% 65
2024
Q4
$5.8M Buy
25,313
+120
+0.5% +$27.5K 0.59% 64
2024
Q3
$5.63M Buy
25,193
+550
+2% +$121K 0.56% 68
2024
Q2
$5.01M Buy
24,643
+1,013
+4% +$206K 0.53% 69
2024
Q1
$5.16M Buy
23,630
+424
+2% +$93.4K 0.55% 68
2023
Q4
$5.27M Hold
23,206
0.6% 62
2023
Q3
$4.67M Sell
23,206
-3,806
-14% -$803K 0.58% 66
2023
Q2
$5.6M Sell
27,012
-698
-3% -$135K 0.67% 59
2023
Q1
$5.46M Sell
27,710
-823
-3% -$169K 0.67% 64
2022
Q4
$5.77M Sell
28,533
-47
-0.2% -$9.19K 0.75% 58
2022
Q3
$5.03M Sell
28,580
-134
-0.5% -$27.4K 0.72% 58
2022
Q2
$5.78M Sell
28,714
-2,262
-7% -$482K 0.77% 58
2022
Q1
$7.02M Sell
30,976
-187
-0.6% -$44K 0.78% 58
2021
Q4
$8.41M Sell
31,163
-399
-1% -$98.8K 0.87% 53
2021
Q3
$7.63M Buy
31,562
+338
+1% +$85.2K 0.88% 52
2021
Q2
$7.4M Sell
31,224
-454
-1% -$103K 0.85% 52
2021
Q1
$6.94M Sell
31,678
-417
-1% -$83.7K 0.85% 53
2020
Q4
$5.61M Sell
32,095
-61
-0.2% -$10.5K 0.73% 57
2020
Q3
$5.2M Buy
32,156
+47
+0.1% +$7.45K 0.75% 57
2020
Q2
$4.58M Buy
32,109
+768
+2% +$106K 0.75% 56
2020
Q1
$3.4M Sell
31,341
-2,342
-7% -$337K 0.66% 60
2019
Q4
$4.89M Buy
33,683
+1,379
+4% +$199K 0.74% 58
2019
Q3
$4.66M Sell
32,304
-239
-0.7% -$34.9K 0.76% 53
2019
Q2
$4.83M Buy
32,543
+1,129
+4% +$158K 0.78% 51
2019
Q1
$4.13M Buy
31,414
+1,135
+4% +$140K 0.7% 57
2018
Q4
$3.29M Buy
30,279
+1,636
+6% +$219K 0.65% 59
2018
Q3
$4.27M Buy
28,643
+1,215
+4% +$185K 0.72% 54
2018
Q2
$4.23M Buy
27,428
+375
+1% +$56.6K 0.77% 51
2018
Q1
$3.76M Sell
27,053
-172
-0.6% -$25.3K 0.69% 57
2017
Q4
$3.68M Buy
27,225
+1,707
+7% +$226K 0.66% 61
2017
Q3
$3.31M Buy
25,518
+1,523
+6% +$203K 0.62% 66
2017
Q2
$3.18M Buy
23,995
+2,140
+10% +$262K 0.63% 68
2017
Q1
$2.69M Buy
21,855
+640
+3% +$75.8K 0.55% 71
2016
Q4
$2.34M Buy
21,215
+3,885
+22% +$432K 0.51% 75
2016
Q3
$2.05M Buy
17,330
+542
+3% +$63.9K 0.46% 77
2016
Q2
$1.88M Buy
16,788
+1,175
+8% +$126K 0.44% 72
2016
Q1
$1.57M Buy
15,613
+1,711
+12% +$164K 0.38% 79
2015
Q4
$1.37M Buy
13,902
+4,924
+55% +$508K 0.36% 80
2015
Q3
$836K Buy
+8,978
New +$929K 0.22% 97

Other funds holding LH

Jacobs & Co's LH Position: Q2 2026 in Review

Jacobs & Co reduced its Labcorp (LH) stake by 8.9% in Q2 2026, selling an estimated $567K and leaving 21,959 shares worth $6.15M. The position accounts for 0.53% of the portfolio, ranked #60.

Jacobs & Co first reported a position in LH in Q3 2015 and has held it in 44 quarters since. The position peaked at $8.41M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Jacobs & Co held 21,959 shares of Labcorp worth $6.15M as of Q2 2026.
  • Jacobs & Co sold 2,158 Labcorp shares in Q2 2026, an estimated $567K.
  • Labcorp made up 0.53% of Jacobs & Co's portfolio in Q2 2026, its #60 holding.
  • Jacobs & Co first reported a position in Labcorp in Q3 2015 and has held it in 44 quarters since.
  • Jacobs & Co's Labcorp position peaked at $8.41M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.